Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

News headlines Vertex Pharmaceuticals (VRTX) faces mixed performance as it prepares for a highly anticipated earnings release. While long-term revenue growth remains strong at 14.4% annually, recent ...

Years ago, an audacious Fields medalist outlined a sweeping program that, he claimed, could be used to resolve a major ...

Shares of Vertex Pharmaceuticals Inc. rose 6.92% to $463.13 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.30% to 6,849.72 ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...

Abstract: This paper proposes a graph linear canonical transform (GLCT) by decomposing the linear canonical parameter matrix into fractional Fourier transform, scale transform, and chirp modulation ...

Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Eric's career includes extensive work in both ...

The Dark Forest theory is one proposed solution to the famed Fermi Paradox, which has bewitched astronomers for more than half a century. To put it concisely, the paradox asks if the cosmos is nearly ...

Richard Thaler doesn’t take himself too seriously, he laughs a lot, answers questions with stories, and his office has an eclectic feeling of being both an academic space and something fun. He admits ...